Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism

BMJ Evid Based Med. 2018 Dec;23(6):230. doi: 10.1136/bmjebm-2018-111007. Epub 2018 Jun 29.
No abstract available

Publication types

  • Review
  • Comment

MeSH terms

  • Heparin, Low-Molecular-Weight*
  • Humans
  • Pyridines
  • Thiazoles
  • Venous Thromboembolism*

Substances

  • Heparin, Low-Molecular-Weight
  • Pyridines
  • Thiazoles
  • edoxaban